NIH is the largest single source of SBIR funding in the US, investing over $1 billion annually through its institutes and centres. Health technology companies - diagnostics, therapeutics, devices, digital health, and research tools - access this funding through a structured two-phase process. This guide explains how NIH SBIR works and how to approach it effectively.
The National Institutes of Health runs the largest SBIR programme of any US federal agency by dollar value. NIH SBIR is different in character from SBIR at defence agencies - it's primarily about scientific merit and public health impact, not operational utility to government. A company doesn't need to sell to NIH or the federal government to qualify; it needs to be developing technology that could improve health outcomes and is scientifically credible. That distinction matters when you're writing an application.
NIH SBIR follows the standard two-phase structure. Phase I is a feasibility award - typically up to $300,000 over 6 months - to establish that the core technical or scientific approach is sound. Phase II follows Phase I success - up to $2 million over 2 years - to develop the technology to a point where commercial or clinical translation is achievable. Phase II applications are only open to Phase I awardees in the NIH system, though some institutes occasionally allow direct Phase II applications from companies with substantial prior work.
The scale of NIH SBIR is worth noting. Over 20 institutes and centres within NIH fund SBIR separately. The National Cancer Institute, National Heart Lung and Blood Institute, and National Institute of Biomedical Imaging and Bioengineering are among the largest. Each has its own research priorities, funding levels, and review panels. The right approach is to identify which institutes have the strongest alignment with your technology before you write a word of an application.
NIH reviews applications against five core criteria: Significance, Innovation, Approach, Investigator, and Environment. Significance means the public health problem is real and important. Innovation means your approach is genuinely new - not incremental improvement on existing technology. Approach is the detailed scientific and technical plan. Investigator means the team has the relevant expertise. Environment means you have the facilities, equipment, and institutional support to do the work.
The most common weakness in NIH SBIR applications from commercial companies is the Investigator section. Reviewers are typically academic scientists, and they look for publications, prior NIH funding, and academic credentials as proxies for scientific credibility. If your founding team doesn't have strong academic credentials, bringing in an academic collaborator as a consultant or Co-Investigator strengthens your application significantly.
NIH reviews SBIR applications at the Scientific Review Group (SRG) level - panels of external scientists convened three times a year. Each application receives written critiques and a numerical priority score. Applications scoring in roughly the top 10-20% move forward for funding consideration - called being "discussed." Most applications get an administrative review and a score without being discussed (informally called "triaged"), meaning they won't be funded in that round. A triaged application can be revised and resubmitted once with an additional introduction addressing reviewer comments.
From submission to funding decision takes about 8-10 months. From funding decision to first payment takes another 2-4 months. Planning a 12-14 month runway from first NIH submission to first dollar in your account is realistic and important for financial planning.
Before submitting, contact the programme officer at the institute you're targeting. Programme officers are NIH staff who manage SBIR portfolios within their institute. They can tell you whether your technology fits their priorities, suggest which funding opportunity announcement to use, and help you understand the review panel your application will go to. This conversation is normal and expected - NIH programme officers are accessible and willing to talk to prospective applicants.
The study section your application is assigned to matters. If reviewers don't understand your technology area, scores suffer. You can request assignment to a specific study section in your application cover letter - and this request is often honored.
Grantscom searches thousands of live grants and tenders every day and scores them against your business profile.
Start free →